The British journal of dermatology
-
Randomized Controlled Trial Multicenter Study Clinical Trial
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.
In previous studies, etanercept significantly improved plaque psoriasis and was well tolerated. ⋯ Etanercept provided clinically meaningful benefit to patients with chronic plaque psoriasis, with no apparent decrease in efficacy after dose reduction.
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial.